# Erlotinib

## Tarceva 150mg

##### 臨採

| TAH Drug Code      | [OTAR1](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OTAR1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Indicated for first-line and maintenance treatment in patients with locally invasive or metastatic non-small cell lung cancer (NSCLC) with EGFR-TK mutations. Also applicable as second-line therapy for patients with lung adenocarcinoma who have previously undergone chemotherapy but still experience local deterioration or metastasis.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Dosing             | [Non–small cell lung cancer (NSCLC) (as first-line therapy, maintenance treatment, or for progressive disease)] 150 mg taken on an empty stomach at least 1 hour before or 2 hours after the ingestion of food. Treatment should continue until disease progression or unacceptable toxicity occurs.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Contraindications  | Hypersensitivity to any component of the formulation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Adverse Effects    | Common: Edema (37%), Alopecia (14%), Pruritus (13-16%), Rash, Any grade (60-85%), Weight decreased (39%), Abdominal pain (11-46%), Diarrhea, Any grade (20-62%), Flatulence (13%), Indigestion (17%), Inflammatory disease of mucous membrane (17-22%), Loss of appetite (52%), Nausea (33-60%), Vomiting (23-42%), Hyperbilirubinemia, Increased liver enzymes, Infectious disease (24-39%), Bone pain (25%), Myalgia (21%), Headache (15%), Conjunctivitis (12-18%), Keratoconjunctivitis sicca (12%), Anxiety (13%), Depression (19%), Cough (16-48%), Dyspnea, Any grade (41-45%), Fatigue (52%), Fever (36%) Serious: Cardiac dysrhythmia (Grade 3 or higher), Myocardial infarction, Syncope (Grade 3 or higher), Rash (Grade 3 or 4) (5-14%), Stevens-Johnson syndrome, Toxic epidermal necrolysis, Bowel obstruction (Grade 3 or higher), Diarrhea (Grade 3 or 4) ( 2-5%), Gastrointestinal hemorrhage, Gastrointestinal perforation, Pancreatitis (Grade 3 or higher), Deep venous thrombosis (3.9%), Microangiopathic hemolytic anemia, With thrombocytopenia (up to 1.4%), Hepatorenal syndrome, Liver failure, Cerebrovascular accident (2.5%), Corneal ulcer, Perforation of cornea, Acute renal failure, Dyspnea (Grade 3 or 4) (8-17%), Interstitial lung disease |
| Pregnancy          | Human (and Animal) Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| More Info          | [UpToDate](https://www.uptodate.com/contents/erlotinib-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |

